The programs that never name the molecule

72 programs in this register, from 64 companies, advertise a GLP-1 and a monthly figure without saying which medicine you would be taking. They ask a median of $153 against $199 for programs that do name it. A price you cannot attach to a molecule is a price you cannot compare.

Computed from the register, as of September 13, 2026

1. What it looks like on the page
2. What these programs charge
3. Why the name is the thing you need
4. What to ask

What it looks like on the page

The wording is consistent across the market and easy to read past: GLP-1 injections, GLP-1 medication, personalized GLP-1 program, each with a figure beside it. Semaglutide and tirzepatide are different medicines with different dosing and different prices, and a program advertising neither by name has told you the category and the cost while leaving out the product.

These are recorded here under a molecule of unspecified GLP-1 rather than guessed at, because the alternative is picking one on a company's behalf and publishing it as fact. 72 entries carry that value, from 64 64 companys.

What these programs charge

The unnamed programs are not the expensive end of this market — they sit at or below the programs that say what they sell. That is worth stating plainly, because the obvious suspicion is that a missing name hides a high price, and in this register it does not. What it hides is which of two medicines you are buying.

62 matched · 72 unnamed-molecule programs assessed · 10 not yet checked · 858 entries in the register

Why the name is the thing you need

Two reasons, and neither is about trust. The first is that you cannot compare the price. A figure for an unnamed GLP-1 sits in the same list as programs quoting semaglutide and programs quoting tirzepatide, which in this register are priced differently from each other — so the cheapest-looking row may be cheap because of what it contains rather than because of what it costs.

The second is that the two medicines are not interchangeable in practice. Dosing schedules differ, tolerability differs between people, and a program that decides for you after you have paid has moved a clinical choice behind a checkout. Where a company names the molecule at a later step, the entry says so.

What to ask

1. Which molecule does this price buy? Semaglutide and tirzepatide are priced differently in this market, so the answer changes what the figure means.
2. Does the price change if the answer changes? Some programs hold one rate across both and say so; others do not.
3. Is it compounded or brand? That question is its own article, and it moves the figure further than almost anything else.

Each of these programs has an entry carrying the company's own sentence, the address it was read from and the date. All of them are listed together, and the data is downloadable.

All articles · Answers · The register · Download the data